Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-cand-3_05-cv-03740/USCOURTS-cand-3_05-cv-03740-72/pdf.json

Nature of Suit Code: 890
Nature of Suit: Other Statutory Actions
Cause of Action: 28:1441 Petition for Removal

---

United States District Court

For the Northern District of California

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

IN THE UNITED STATES DISTRICT COURT

FOR THE NORTHERN DISTRICT OF CALIFORNIA

THE COUNTY OF SANTA CLARA, on behalf

of itself and all others similarly situated,

Plaintiffs,

 v.

ASTRA USA, INC., ASTRA ZENECA

PHARMACEUTICALS LP, EVENTS

PHARMACEUTICALS, INC., BAYER

CORPORATION, BRISTOL-MYERS SQUIBB

COMPANY, PFIZER, INC.,

SCHERING-PLOUGH CORPORATION TAP

PHARMACEUTICAL PRODUCTS, INC.,

ZENECCA, INC., ZLB BEHRING LLC,

SMITHKLINE BEECHAM CORPORATION,

SMITHKLINE BEECHAM CORPORATION

d/b/a GLAXO SMITHKLINE, WYETH, INC.,

WYETH PHARMACEUTICALS, INC.,

Defendants. /

No. C 05-03740 WHA

ORDER REGARDING

DEFENDANT AVENTIS’S

REQUEST TO FILE A REPLY

IN SUPPORT OF ITS

OBJECTION TO PLAINTIFF’S

DESIGNATION OF AMBIEN

IN DISCOVERY REQUESTS

Defendant Aventis Pharmaceuticals Inc. has requested leave to file a reply in support of

its objection to plaintiff’s designation of Ambien in Stage Two discovery. Defendant shall file a

reply brief of no more than 4 pages no later than NOON ON FRIDAY, AUGUST 13, 2010. 

IT IS SO ORDERED.

Dated: August 13, 2010. WILLIAM ALSUP

UNITED STATES DISTRICT JUDGE

Case 3:05-cv-03740-WHA Document 689 Filed 08/13/10 Page 1 of 1